QNZ46
QNZ46 is a selective non-competitive antagonist targeting NMDA receptors containing the NR2C or NR2D subunits. It is a valuable research tool for studying synaptic plasticity, neuropathic pain mechanisms, and the role of specific NMDA receptor subtypes in both in vitro and in vivo neurological models.
Product Specifications
CAS Number
1237744-13-6
Product Name Alternative
IGluR, Inhibitor, NR2C, NR2D, NR2A, inhibit, Ionotropic glutamate receptors, QNZ 46, QNZ46, QNZ-46
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
99.64% (May vary between batches)
Solubility
DMSO:4.44 mg/mL (10.01 mM)
Smiles
COc1ccc2nc (\C=C\c3cccc (c3) [N+] ([O-]) =O) n (-c3ccc (cc3) C (O) =O) c (=O) c2c1
Molecular Formula
C24H17N3O6
Molecular Weight
443.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRV-0020663-01 50 Tests
Anti-CD300 Antigen Like Family Member C (CD300c) Polyclonal Antibody
Sign In for Pricing
View Details TRV-0020663-02 100 Tests
Anti-CD300 Antigen Like Family Member C (CD300c) Polyclonal Antibody
Sign In for Pricing
View Details TRV-0020663-03 200 Tests
Anti-CD300 Antigen Like Family Member C (CD300c) Polyclonal Antibody
Sign In for Pricing
View Details